Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
6.14
+0.27 (4.60%)
Aug 22, 2025, 4:00 PM - Market closed

Entrada Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
79.48210.78129.01---
Upgrade
Revenue Growth (YoY)
-66.80%63.38%----
Upgrade
Cost of Revenue
134.61125.3199.8866.6135.93-
Upgrade
Gross Profit
-55.1485.4829.13-66.61-35.93-
Upgrade
Selling, General & Admin
41.0338.4732.2930.6415.25.57
Upgrade
Research & Development
-----21.1
Upgrade
Operating Expenses
41.0338.4732.2930.6415.226.67
Upgrade
Operating Income
-96.1647.01-3.16-97.25-51.13-26.67
Upgrade
Interest & Investment Income
19.2619.4715.222.630.040.16
Upgrade
EBT Excluding Unusual Items
-76.9166.4912.06-94.62-51.08-26.5
Upgrade
Gain (Loss) on Sale of Assets
-----0.07-0.02
Upgrade
Pretax Income
-76.9166.4912.06-94.62-51.16-26.52
Upgrade
Income Tax Expense
-3.550.8618.74---
Upgrade
Net Income
-73.3565.63-6.69-94.62-51.16-26.52
Upgrade
Net Income to Common
-73.3565.63-6.69-94.62-51.16-26.52
Upgrade
Shares Outstanding (Basic)
4137333161
Upgrade
Shares Outstanding (Diluted)
4139333161
Upgrade
Shares Change (YoY)
19.72%18.01%5.62%399.27%467.09%18.45%
Upgrade
EPS (Basic)
-1.791.76-0.20-3.02-8.16-24.00
Upgrade
EPS (Diluted)
-1.791.68-0.20-3.02-8.16-24.00
Upgrade
Free Cash Flow
-126.56-44.72134.19-96.67-55.44-27.89
Upgrade
Free Cash Flow Per Share
-3.09-1.154.06-3.09-8.85-25.23
Upgrade
Gross Margin
-69.38%40.55%22.58%---
Upgrade
Operating Margin
-121.00%22.30%-2.45%---
Upgrade
Profit Margin
-92.30%31.14%-5.18%---
Upgrade
Free Cash Flow Margin
-159.24%-21.21%104.01%---
Upgrade
EBITDA
-92.2650.78-0.32-95.35-50.01-26.34
Upgrade
EBITDA Margin
-116.08%24.09%-0.25%---
Upgrade
D&A For EBITDA
3.913.772.841.91.120.33
Upgrade
EBIT
-96.1647.01-3.16-97.25-51.13-26.67
Upgrade
EBIT Margin
-121.00%22.30%-2.45%---
Upgrade
Effective Tax Rate
-1.29%155.45%---
Upgrade
Updated Aug 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q